Special Issue “New Advances in Leishnmaniasis”

https://www.mdpi.com/journal/microorganisms/special_issues/leishnmaniasis

Dear Colleagues,

We are proud to announce a Special Issue, “New advances in Leishnmaniasis”, in Microorganism (MDPI; IF 4.167) devoted to the 2nd International Caparica Conference on Leishmanisis 2020 (2nd Leishmaniasis-2020) (http://www.leishmaniais2020.com/).

Millions of people are currently affected by the parasite Leishmania, every year some millions are expected to be infected, and hundreds of deaths occur daily. The man´s best friend is also affected by this disease. However, the extension of this disease in dogs is difficult of accurate estimation. Leishmaniasis is a terrible disease that requires quick intervention. It causes open wounds that may not heal on its own. Also, visceral leishmaniasis is fatal if untreated. For humans living in developed countries is a problem. For people living in emerging countries, it can be the cause of death.  It is indeed a sentence of death for abandoned dogs1. 1(BA 1st ICC on Leishmanisis 2018)

This Special Issue will select excellent papers as well as review articles from the oral (plenary, keynotes, and regular talks) and selected poster participations, and covers a very wide range of fields in studies, treatments, emerging drugs, prevention strategies, new compounds against canine, feline, human and/or cutaneous and/or visceral leshmaniasis applications presented in the 2nd International Caparica Conference on Leishmanisis 2020 (2nd Leishmaniasis-2020). We invite all the researchers to contribute original research articles or reviews to this Special Issue.

Dr. Carlos Lodeiro
Dr. Jose Luis Capelo
Dr. Hugo Miguel Santos
Guest Editors

Dead line:  January 30th, 2021

More information in: Link: 

Keywords:

Leihsmanisis, canine, human, prevention, treatment, drug-resistance

We have an agreement in the reduce article processing charges in 20% for participants and 20% in PROTEOMASS Scientific Society Members over the regular price. The final publishing fee for an accepted paper will be 1280 CHF after 20% reduction (320 CHF discount). 

Guest Editor:
Name: Prof. Dr. Jose Luis Capelo
Email: jlcm@fct.unl.pt
Affiliation: BIOSCOPE Group, LAQV@REQUIMTE, Chemistry Department, Faculty of Science and Technology, NOVA University Lisbon, Caparica, Portugal
Homepage: https://www.dq.fct.unl.pt/en/staff/professors/jose-luis-capelo-martinez
Interest Keywords: Antibiotic résistance; MALDI-TOF mass spectrometry; analytical proteomics; biomarker discovery; aAnalytical chemistry; biochemistry.

Guest Editor:
Name: Prof. Dr. Carlos Lodeiro
Email: cle@fct.unl.pt
Affiliation: BIOSCOPE Group, LAQV@REQUIMTE, Chemistry Department, Faculty of Science and Technology, NOVA University Lisbon, Caparica, Portugal
Homepage: https://www.dq.fct.unl.pt/en/staff/professors/carlos-lodeiro-espino
Interest Keywords: Nanoparticles; Fluorescence; Chemosensors; Proteomics; Nanomaterials

Guest Editor:

Name: Dr. Hugo Miguel Santos
Email: hmsantos@fct.unl.pt
Affiliation: BIOSCOPE Research Group, LAQV, REQUIMTE, Department of Chemistry, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
Homepage: http://www.bioscopegroup.org/index.php/people?id=17
Interest Keywords: proteomics;